As part of the 10th annual awards program, Welldoc recognized for continued AI leadership and innovation across cardiometabolic health
COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®, an AI-powered health technology leader, today announced that it has been named winner of the “Best Overall Digital Health Company” award for the fourth consecutive year in the MedTech Breakthrough Awards. The annual awards program is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies and products in the global digital health and medical technology market. This is the fifth year overall that MedTech Breakthrough has recognized Welldoc for its leadership and innovation in the digital health industry.
Welldoc has continued to demonstrate its clinical rigor and the ongoing evolution of its healthcare-ready AI. The company surpassed 100 peer-reviewed clinical publications, including 43 focused specifically on AI, and formally launched the Welldoc AI Lab. Backed by academic partnerships with Johns Hopkins University and the Vellore Institute of Technology, the Lab is advancing next-generation healthcare AI, including proprietary Small Language Models, Large Sensor Models and generative AI applications. The Welldoc Platform was recently awarded the DiMe Seal for demonstrated performance against rigorous standards and best practices in evidence, privacy, security, and usability. Welldoc also submitted a 510(k) premarket notification to the FDA for its Continuous Glucose Monitor (CGM)-Informed Glucose Prediction Feature. The ‘CGM-GPT’ feature is designed to leverage real-time continuous glucose sensor data to inform glucose prediction, representing a meaningful step forward in Welldoc’s AI development pipeline.
“In a landscape defined by rapid AI momentum, Welldoc continues to lead by combining high-speed innovation with the rigorous demands of clinical medicine,” said Kevin McRaith, President and CEO of Welldoc. “By intentionally developing sophisticated AI that extends far beyond wellness, we provide a robust, unified platform that helps individuals navigate complex conditions while connecting clinicians to the insights needed to optimize clinical decisions. This award validates our commitment to delivering the clinically precise coaching and high-momentum solutions required to meet the highest standards of evidence, safety and trust.”
Now celebrating its 10th anniversary, the MedTech Breakthrough Awards program has spent a decade recognizing the companies driving meaningful progress and improving patient care across the global health and medical technology industry. This year’s program drew a record-breaking number of nominations from leading companies and startups across more than 20 countries, reflecting the growing global impact and momentum of the digital healthcare industry.
“Individuals living with complex conditions face daily challenges that require constant management and effort, and Welldoc makes it seamless for them and their providers to manage multiple conditions in one place. Welldoc’s clinically validated AI bridges what healthcare keeps apart,” said Steve Johansson, managing director, MedTech Breakthrough. “We extend our sincere congratulations to the Welldoc team for their well-deserved 2026 MedTech Breakthrough Award win.”
About Welldoc
Welldoc® is an AI-powered health technology leader committed to connecting people to better, more personalized cardiometabolic care. The company’s digital health platform delivers a unified experience for individuals managing diabetes, obesity (including GLP-1 support), hypertension, heart failure, and complex comorbidities including diabetes in pregnancy, sleep apnea, chronic kidney disease (CKD), and metabolic dysfunction-associated steatohepatitis (MASH).
The foundation of Welldoc’s solution is healthcare-ready AI, a purpose-built engine grounded in unmatched clinical rigor, with 11 FDA clearances, 67 patents, and more than 100 peer-reviewed publications demonstrating clinical effectiveness and safety. The platform’s architecture allows individuals to connect to over 400 devices and data sources, while also integrating seamlessly with electronic health record (EHR) systems, to enable comprehensive data interoperability across care settings.
Welldoc partners across multiple healthcare sectors—including life sciences companies, health plans, health systems, and employers—to drive innovative health programs, improved patient outcomes, and reduced costs at scale. The company is also strategically aligned with federal modernization efforts. Welldoc has been recognized as a leader in healthcare innovation, named one of TIME and Statista’s World’s Top HealthTech Companies and awarded “Best Overall Digital Health Company” by MedTech Breakthrough™ for four consecutive years. For more information, visit www.welldoc.com.
About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.
Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.
Contacts
Sylvia Aranda
Real Chemistry
[email protected]
